INTRODUCTION
The genus Yersinia (Y.) comprises a large group of gram-negative, facultatively anaerobic bacteria belonging to the family Enterobacteriaceae. Widespread in the environment and amongst animal populations, the genus is clinically important as some members are pathogenic and are the etiological agents of several diseases in humans. 1 Pathogenic members of the genus are responsible for a number of fatal and non-fatal infections, ranging from the relatively mild gastrointestinal disease yersiniosis (Y. enterocolitica) to the potentially fatal bubonic plague (Y. pestis). 2, 3 Furthermore, these organisms are zoonotic pathogens and may persist in non-human reservoirs until they are able to infect humans. This poses a unique set of problems otherwise not encountered in the prevention of other diseases, as traditional methods (isolation of infected individuals, targeted immunization) are less effective in the treatment of zoonotic infections. 4 Yersiniosis is an acute gastrointestinal infection acquired through the ingestion of contaminated food or water. Characterised by abdominal pain, diarrhoea and fever, yersiniosis is a significant disease which accounts for over 100,000 cases of gastroenteritis in the US annually. 5 The disease originates from several sources although it is a predominately food-borne illness and transmission of this type accounts for approximately 90% of all reported cases. 6 Y. enterocolitica has the ability to grow at 4 o C and thus refrigeration is an inadequate means of protection from infection. 7 Although rarely fatal and often self-limiting, the symptoms associated with yersiniosis can result in sufferers becoming temporarily incapacitated and thus has indirect negative economic consequences. The probing of natural reservoirs for antibacterial agents effective in the growth inhibition of Y. enterocolitica offers an alternative approach in the prevention and treatment of these infections. Terminalia ferdinandiana Exell (Kakadu plum, gubinge) is an endemic Australian plant which has an extremely high antioxidant content. 8, 9 The fruit of this plant also has the highest ascorbic acid levels of any plant in the world, with levels reported as high as 6% of the recorded wet weight. 8, 9 This is approximately 900 times higher (g/g) than the ascorbic acid content in blueberries (which are themselves considered a good source of antioxidants). The medicinal benefits of the fruit were well known by the first Australians who considered the plum both a medicine and a nutritious food source. It has been proposed that many of the health benefits of the fruit may stem from the growth inhibitory activity of its many antimicrobial compounds. 10 These include flavonoids, benzoic acid derivatives, as well as gallic acid and ellagic acid derivatives, all of which have been previously associated with microbial inhibition. 11 Indeed, the antiseptic potential of the fruit is well documented in the prevention of several disease-causing microorganisms. [12] [13] [14] [15] Recently, T. ferdinandiana leaf extracts were also shown to have antibacterial activity. 16 Potent growth inhibitory activity was reported against the bacterial triggers of several auto-immune inflammatory diseases including rheumatoid arthritis 16 The study indicated that the inhibition of the bacterial growth by the leaf extracts may be due to their high tannin content. Despite these studies and the extremely high antioxidant capacity of T. ferdinandiana, it is yet to be evaluated for the ability to inhibit the growth of the food poisoning bacterium Y. enterocolitica.
MATERIALS AND METHODS

Plant source and extraction
T. ferdinandiana fruit pulp and leaves were provided and verified courtesy of David Boehme of Wild Harvest, Northern Territory (Australia). The pulp was frozen prior to transport and stored at-10 o C until processing. A voucher specimen of the pulp (KP2014GD) is maintained at School of Natural Sciences, Griffith University. The pulp and leaves were extensively dehydrated in a Sunbeam food dehydrator and the desiccated material was stored at-30 o C. A voucher specimen (KP2015LA) is stored at the School of Natural Sciences, Griffith University. The plant materials were comprehensively dried and ground into a coarse powder prior to use. A mass of 1 g of ground powder was extensively extracted individually by maceration in 50 mL of deionised water, methanol, hexane, ethyl acetate orchloroform for 24 h at 4 o C with gentle shaking. All solvents were supplied by Ajax, Australia and were AR grade. The extracts were filtered through filter paper (Whatman No. 54) and air dried at room temperature. The aqueous extract was lyophilised by rotary evaporation in an Eppendorf concentrator 5301. The subsequent pellets were dissolved in 10 mL deionised water (containing 0.5 % DMSO). The extract was passed through a 0.22 μm filter (Sarstedt) and stored at 4°C until used.
Qualitative phytochemical studies
Phytochemical analysis of the extracts for the presence of tannins, triterpenoids, saponins, flavonoids, phytosteroids, phenolic compounds, anthraquinones, cardiac glycosides and alkaloids were conducted by previously described assays.
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Antioxidant capacity
The antioxidant capacity of each sample was assessed using a modified DPPH free radical scavenging method. [20] [21] [22] Ascorbic acid (0-25 µg per well) was used as a reference and the absorbances were measured and recorded at 515 nm. All tests were performed in parallel with controls on each plate and all were performed in triplicate. The antioxidant capacity based on DPPH free radical scavenging ability was determined for each extract and expressed as µg ascorbic acid equivalents per gram of original plant material extracted.
Antibacterial screening Clinical Yersinia enterocolitica strain
The clinical isolate strain of Yersinia enterocolitica used in this study was supplied by Ms. Jane Gifkins of the School of Natural Sciences Griffith University, Australia. All growth studies were performed using nutrient agar (Oxoid Ltd., Australia) under aerobic conditions. Incubation was at 30 o C and the stock culture was subcultured and maintained in nutrient broth at 4 o C.
Evaluation of antimicrobial activity
Antimicrobial activity of all plant extracts was determined using a modified disc diffusion assay. [23] [24] [25] Briefly, 100 µL of Y. enterocolitica was grown in 10 mL of fresh nutrient broth until they reached a count of ~10 8 cells/mL. A volume of 100 µL of the bacterial suspension was spread onto nutrient agar plates and extracts were tested for antibacterial activity using 5 mm sterilised filter paper discs. Discs were infused with 10 µL of T. ferdinandiana extracts, allowed to dry and placed onto the inoculated plates. The plates were allowed to stand at 4°C for 2 h before incubation at 30°C for 24 h. The diameters of the inhibition zones were measured to the closest whole millimetre. Each assay was performed in at least triplicate. Mean values (± SEM) are reported in this study. Standard discs of chloramphenicol (10 µg) were obtained from Oxoid, Australia and were used as positive controls to compare antibacterial activity. Filter discs infused with 10 µL of distilled water were used as a negative control.
Minimum inhibitory concentration (MIC) determination
The minimum inhibitory concentrations (MIC) of the extracts was determined as previously described. 26 Briefly, the plant extracts were diluted in deionised water and tested across a range of concentrations. Discs were infused with 10 µL of the extract dilutions, allowed to dry and placed onto inoculated plates. The assay was performed as outlined above and graphs of the zone of inhibition versus concentration were plotted. Linear regression was used to determine MIC values.
Toxicity screening
Reference toxin for toxicity screening Potassium dichromate (K 2 Cr 2 O 7 ) (AR grade, Chem-Supply, Australia) was prepared in distilled water (4 mg/mL) and serially diluted in artificial seawater for use in the Artemia franciscana nauplii bioassay.
Artemia franciscana nauplii toxicity screening
Toxicity was tested using a modified Artemia franciscana nauplii lethality assay. [27] [28] [29] Briefly, 400 µL of seawater containing ~43 (mean 43.2, n=155, SD 14.5) A. franciscana nauplii were added to wells of a 48 well plate and immediately used in the bioassay. Volumes of 400 µL of the reference toxin or the diluted plant extracts were transferred to the wells and incubated at 25 ± 1°C under artificial light (1000 Lux). A negative control (400 µL seawater) was run in triplicate for each plate. All treatments were performed in at least triplicate. The wells were checked at regular intervals and the number of dead counted. Mortality was determined if no movement of the appendages was detected within 10 sec. After 24 h, all nauplii were sacrificed and counted to determine the total % mortality per well. The LC 50 with 95% confidence limits for each treatment was calculated using probit analysis.
Non-targeted GC-MS analysis
Separations were performed with a Shimadzu GC-2010 Plus (USA) linked to a Shimadzu MS TQ8040 (USA) mass spectrometer. The system was equipped with a Shimadzu auto-sampler AOC-5000 Plus (USA). Chromatographic separation was accomplished using a (5% phenyl, 95% dimethyl polysiloxane, 30 m×0.25×0.25 um) capillary column, obtained from (Restek USA). Helium (99.999%) was employed as a carrier gas at a flow rate of 0.75 mL/min at a split ratio of 21:1. The injector temperature was set at 280°C. The initial column temperature was held at 40°C for 5 min, with an initial ramp at 5°C/min to acquire a temperature of 140°C which was subsequently maintained for a further minute. A second ramp was initiated at 20°C per minute, to attain a column temperature of 260°C, and held for a minute. The third ramp of 50°C/min was undertaken to reach a final temperature of 300°C, which was maintained for a duration of 5 min. The mass spectrometer was operated in the electron ionisation mode at 70eV. The analytes were then recorded in total ion count (TIC) mode. The TIC was acquired after a min and for a duration of 38. 
indicates a minor response; ++ indicates a moderate response; +++ indicates a major response.-indicates no response in the assay. KPLW=aqueous T. ferdinandiana leaf extract; KPLM=methanolic T. ferdinandiana leaf extract; KPLC=chloroform T. ferdinandiana leaf extract; KPLH=hexane T. ferdinandiana leaf extract; KPLE=ethyl acetate T. ferdinandiana leaf extract; KPFW=aqueous T. ferdinandiana fruit extract; KPFM=methanolic T. ferdinandiana fruit extract; KPFC=chloroform T. ferdinandiana fruit extract; KPFH=hexane T. ferdinandiana fruit extract; KPFE=ethyl acetate T. ferdinandiana fruit extract. Antioxidant capacity was determined by DPPH reduction and is expressed as mg ascorbic acid equivalents per gof original plant material extracted. The relative abundance is a measure of the area under the peak expressed as a % of the total area under all chromatographic peaks. The relative abundance is a measure of the area under the peak expressed as a % of the total area under all chromatographic peaks.
Statistical analysis
Data is expressed as the mean ± SEM of at least three independent experiments.
RESULTS
Liquid extraction yields and qualitative phytochemical screening
T. ferdinandiana solvent extractions yielded dried plant extracts ranging from 58 mg to 471 mg (leaf extracts) and from 18 mg to 483 mg (fruit extracts) ( Table 1 ). Methanolic and aqueous extracts provided considerably greater yields of extracted material relative to the ethyl acetate, chloroform and hexane counterparts, which gave low to moderate yields. The dried extracts were resuspended in 10 mL of deionised water (containing 1% DMSO), resulting in the concentrations presented in Table 1 .
Antioxidant content
Antioxidant capacity for the plant extracts (Table 1 ) ranged from 0.4 mg (hexane leaf extract) to a high of 660 mg (methanolic fruit extract) ascorbic acid equivalence per gram of dried plant material extracted. The methanolic and aqueous extracts typically had higher antioxidant capacities than the corresponding ethyl acetate, hexane and chloroform extracts.
Antimicrobial activity
To determine the ability of the T. ferdinandiana fruit and leaf extracts to inhibit Y. enterocolitica growth, 10 µL of each extract was screened using a disc diffusion assay. Bacterial growth was strongly inhibited by 8 of the 10 extracts screened (80%) (Figure 1 ). The aqueous and methanolic leaf extracts were the most potent inhibitors of growth (as judged by zone of inhibition), with inhibition zones of 18 ± 0.6 and 17.3 ± 1.5 mm respectively. This compares positively with the chloramphenicol control (10 µg; inhibition zone=9 ± 0.6 mm). The methanolic fruit extract also displayed good inhibition of Y. enterocolitica growth, with a zone of inhibition ≥ 15 mm. Typically, the leaf extracts were more potent inhibitors of Y. enterocolitica growth than the corresponding fruit extracts (as judged by inhibition zone). The antimicrobial efficacy was further quantified through the determination of MIC values against the T. ferdinandiana extracts ( Table 2) . Most of the extracts were effective at inhibiting Y. enterocolitica growth with MIC values <1000 µg/mL determined for several of the extracts (<10 µg impregnated in the disc). The methanolic extracts of both the leaf and fruit were particularly potent, with MIC values of 372 µg/mL (approximately 3.7 µg infused into the disc) and 123 µg/mL(approximately 1.2 µg infused into the disc) respectively. These results compare well with the growth inhibitory activity of the chloramphenicol controls which were tested at 10 µgper disc. The aqueous and ethyl acetate leaf extracts, as well as the fruit ethyl acetate extract, were also potent Y. enterocolitica growth inhibitors (MIC values of 588, 1100 and 285 µg/mL respectively). Whilst less potent, the leaf chloroform (MIC=5900 µg/mL) and hexane extracts (MIC=5800 µg/mL), as well as the fruit chloroform extract (MIC=6200 µg/mL), also inhibited Y. enterocolitica growth. Their MIC values indicate moderate to low inhibitory activity.
Quantification of toxicity
All extracts were initially screened in the assay at 2000 µg/mL ( Figure 2 ). As a reference toxin, potassium dichromate was also tested in the bioassay. The reference toxin was prompt in its onset of mortality, inducing nauplii death within the first 3 h of exposure and 100 % mortality was evident within 4-5 h (unpublished results). All methanolic, aqueous extracts and ethyl acetate leaf extracts showed > 90 % mortality rates at 24 h. All other extracts exhibited< 10% mortality rates at 24 h with the exception of the chloroform leaf extract.
To further assess the effects of toxin concentration on the initiation of mortality, the extracts were serially diluted in artificial seawater to test across a series of concentrations in the Artemia nauplii bioassay. The LC 50 values of the T. ferdinandiana extracts towards A. franciscana following 24 h exposure are displayed in Table 2 . No LC 50 values are reported for the chloroform or hexane extracts, nor for the ethyl acetate fruit extract as < 50 % mortality was seen in all tested concentrations. Extracts with an LC 50 greater than 1000 μg/mL towards Artemia nauplii have previously been defined as nontoxic in this assay. 30 As only the ethyl acetate fruit extract had an LC 50 value of < 1000 μg/ml, all other extracts were considered nontoxic. Whilst the LC 50 value for the ethyl acetate leaf extract is < 1000 μg/mL, a value of 767 μg/mL is representative of low to moderate toxicity.
GC-MS head space analysis
As the T. ferdinandiana leaf and fruit methanolic extracts were the most potent inhibitor of Y. enterocolitica (as judged by MIC), they were considered the most promising extracts for further phytochemical analysis. Optimised GC-MS parameters were developed and used to examine these extracts. Numerous overlapping peaks were evident in the methanolic fruit extract chromatogram (Figure 3) . A total of 57 peaks were detected and putatively identified in that extract, with prominent peaks eluting at 10.2 min (1-(3H-imidazol-4-yl)-ethanone), 12.3 min (methyl-2-furoate), 14.1 min (2-ethylhexanol), 15.5 min (cis-linalool oxide), 16 .0 min (trans-linalool oxide), 17.9 min (2-(cyanoimino) oxazolidine, 19.7 min (2-methyl-2-phenyl-oxirane), 20.9 min (1,3-bis(1,1-dimethylethyl)-benzene) and 28.9 min (3,5-bis(1,1-dimethylethyl)-phenol). Numerous overlapping peaks were also evident throughout the chromatogram, with a broad range of retention times, particularly between 10 and 25 min, attesting to the wide range of compounds of widely varying polarities in the methanolic fruit extract.
The T. ferdinandiana methanolic leaf extract GC-MS chromatogram ( Figure 4 ) was substantially less complex than the corresponding fruit extract chromatogram. Indeed, only 15 peaks were detected and putatively identified in this chromatogram. Major peaks were evident at 11.3 min (methoxy-phenyl-oxime), 13.8 min (1-octen-3-ol), 14.4 min (2-(1,1-dimethylethoxy)-ethanol, 21.5 min (3,5-dimethyl-benzaldehyde) and 26.5 min (2-methyl-3-hydroxy-2,2,4-propanoic acid). Further prominent peaks were present at 17.0, 18.2, 19.6 and 24.8 min. However, the compound database used in our studies was unable to putatively identify these compounds. Table 4 lists only the compounds which were putatively identified by comparison with the compound database.
DISCUSSION
Many Terminalia spp. have a history of therapeutic usage to treat microbial infections and numerous recent investigations have reported on their antibacterial properties. 31 The Australian species T. ferdinandiana has proven to be particularly effective, with growth inhibitory activity reported against a broad panel of bacterial pathogens, 32 including several bacteria associated with diarrhoea and dysentery. 32, 33 T. ferdinandiana extracts also inhibit the growth of bacterial triggers of rheumatoid arthritis 14, 16 and multiple sclerosis. 13 Furthermore, T. ferdinandiana has also recently been reported to inhibit the proliferation of the gastrointestinal protozoan parasite Giardia duodenalis, 11 indicating its therapeutic potential against both prokaryotic and eukaryotic pathogens. However, despite the wealth of information into the therapeutic potential of T. ferdinandiana, it is yet to be comprehensively studied for antibacterial activity against many bacterial species associated with food poisoning. Here we report, growth inhibitory activity for T. ferdinandiana extracts against the bacterial cause of the gastrointestinal disease yersiniosis, an acute infection acquired through the ingestion of food (particularly pork) 34 contaminated with Y. enterocolitica bacteria.
Potent Y. enterocolitica growth inhibitory activity was evident in the T. ferdinandiana fruit and leaf extracts. The methanolic extracts were the most potent growth inhibitors, with MIC values of 123 and 372 µg/mL for the fruit and leaf extracts respectively. Qualitative GC-MS analysis of these extracts identified a number of interesting compounds which may contribute to this activity. The presence of the furan compounds methyl 2-furoate (Figure 5c ), linalool oxide (Figure 5e ), furylhydroxymethyl ketone (Figure 5g ),1-(2-furanyl)-ethanone ( Figure 5i ) 5-hydroxymethylfurfural (Figure 5o ) in the methanolic T. ferdinandiana extracts is particularly noteworthy as many furan derivatives are potent inhibitors of bacterial growth. The nitro furans have particularly well studied antimicrobial mechanisms, acting via the inhibition of nucleic acid synthesis. 35 Thus, the furan compounds in this extract may have cytostatic Y. enterocolitica growth inhibitory mechanisms although this is yet to be investigated. Further studies reported synthetic furan derivatives (modified by the addition of a rhodanine moiety) to be potent inhibitors of the growth of a panel of multidrug resistant bacteria, with MIC values as low as 2 µg/mL against some species.
36 Whilst we were unable to find reports of anti-bacterial activity for the furan derivatives present in the T. ferdinandiana extracts, it is possible that they may contribute to the growth inhibitory activities reported in our study. Also noteworthy, an imidazole compound,1-(3H-imidazol-4-yl)-ethanone (Figure 5a ), was putatively identified in the methanolic T. ferdinandiana fruit extract. Several imidazo-compounds (e.g. metronidazole, azanidazole tinidazole) have notable antibiotic activity. 37 Interestingly, similar imidazole compounds also have inhibitory activity against eukaryotic parasites. 40 Indeed, anti-giardial activity has been reported for T. ferdinandiana fruit extract. 11 A variety of benzene and benzoic acid derivatives including benzaldehyde (Figure 5b ), benzene acetaldehyde (Figure 5d), bicyclo[4.2.0]octa-1,3,5-trien-7-ol (Figure 5f ), benzhydrazide Figure 6g) were putatively identified in the leaf methanolic extract. Several studies have previously reported potent antibacterial activity for phenolic benzaldehyde and benzoic acid derivatives. 38 Thus, these compounds may also contribute to the Y. enterocolitica growth inhibitory activity reported in our study. Several monoterpenoids were also putatively identified in the methanolic T. ferdinandiana extracts, with cis-and trans-linalool oxide (Figure 5e ), camphor ( Figure 5j ) and borneol (Figure 5l ) identified in the fruit extract. Linalool oxide was also present in the leaf methanolic extract, together with cineole (Figure 6b ). Several other important terpenoids have also been reported in T. ferdinandiana extracts in recent studies using different analytical techniques. 13 Monoterpenoids were particularly prevalent in those studies, with isomyocorene, cineole, cuminol, camphor andisomenthol reported in T. ferdinandiana fruit extracts. Many of these terpenoids have potent broad spectrum antibacterial activity 39, 42 and therefore may contribute to the Y. enterocolitica growth inhibitory activity. It is also likely that other phytochemical classes contribute to the growth inhibitory properties of these extracts. Our qualitative phytochemical screening studies indicate that polyphenolics, flavonoids, saponins, and terpenes were present in the T. ferdinandiana extracts. As our study used GC-MS techniques to putatively identify the phytochemical composition of the extracts, many of the mid to higher polarity compounds may have not been identified. Recent studies have reported the LC-MS profiles of similar T. ferdinandiana fruit 11, 14 and leaf extracts. 16 Several features were common to all of these studies. All reported a diversity of tannins in both the fruit and leaf extracts. Gallic acid, ellagic acid and their methylated derivatives, chebulic acid, galloyl pyrogallol, corilagen, punicalin, castalagin and chebulagic acid were previously reported in similar T. ferdinandiana extracts to those tested in our study. These tannins have potent, broad spectrum growth inhibitory activity against a variety of bacterial species. 40 Gallotannins have particularly well reported inhibitory properties. 41 They function via multiple mechanisms including interacting with both cell surface proteins 43, 44 and through interactions with intracellular enzymes. 45 Ellagitatannins also interact with cellular proteins and induce disruptions in bacterial cell walls. 41, 43 Recent studies also highlighted the stilbene components of T. ferdinandiana fruit extracts. 13, 14 Resveratrol and the glycosylated resveratrol derivative piceid, diethylstilbestrol monosulfate and combretastatin A1 were putatively identified in those studies. Identification of combretastatin A1 was particularly interesting as combretastatins have attracted much recent interest due to their potent ability to block cancer cell progression and induce apoptosis by binding intracellular tubulin, thereby disrupting microtubule formation. 42 Whilst we were unable to find accounts of bacterial growth inhibition of combretastatin A1 in the literature, the growth inhibition of Staphylococcus aureus, Streptococcus pneumoniae, Escherichia coli and Neisseria gonorrhoeae by several synthetic combretastatins (and synthetic resveratrol analogues) have been reported. 43 Therefore, it is likely that the T. ferdinandiana extract stilbene components may also contribute to the Y. enterocolitica growth inhibition noted in our study. The findings reported here also indicate that the T. ferdinandiana fruit and leaf extracts were generally nontoxic, with LC 50 values substantially >1000 µg/mL in the Artemia nauplii bioassay. Indeed, only the T. ferdinandiana leaf ethyl acetate extract had an LC 50 value<1000 µg/mL. Whilst this extract inhibited Y. enterocolitica growth, the MIC value of 1100 µg/mL is indicative of moderate growth and thus has lower therapeutic potential in the treatment of yersiniosis compared to the methanolic extracts. Furthermore, an LC 50 value of 767 µg/mL indicate low to moderate toxicity. However, this toxicity may impact on the usefulness of the leaf ethyl acetate extract as a medicinal antiseptic agent. Similar extracts prepared from fruits of these species have previously been reported to have high ascorbic acid levels. 9 Whilst these ascorbic acid levels may have beneficial therapeutic effects, they may also be responsible (at least in part) for the toxicity reported here. Whilst A. franciscana have generally been reported to be a robust and hardy organism for toxicity screening, they are susceptible to pH changes. 30 The levels of ascorbic acid previously reported in the T. ferdinandiana leaf ethyl acetateextract 13, 14 would be expected to have a significant impact on the pH of the seawater in the tests and this change may be responsible for the mortality induction reported in our study. Indeed, studies in our laboratory have shown that testing pure ascorbic acid in the concentrations previously reported to be in these extracts results in mortality similar to that reported here (unpublished results). Toxicity was assessed in this study with the test organism A. franciscana. The lack of toxicity of these extracts indicates that they are likely to be safe for medicinal usage. This is hardly surprising as T. ferdinandiana is a food which is reputed to be highly nutritious. However, whilst the extracts examined in this report have potential as Y. enterocolitica growth inhibitory agents, caution is needed before these compounds can be applied to medicinal purposes. Toxicity towards A. franciscana has previously been shown to correlate well with toxicity towards human cells for many toxins. 30 However, further studies are required to determine whether this is also true for the T. ferdinandiana extracts examined in these studies. The results of this study indicate that the T. ferdinandiana extracts examined in this study warrant further study due to their Y. enterocolitica growth inhibitory activity. Purification and identification of the bioactive components is needed to examine the mechanisms of action of these agents.
CONCLUSION
The results of this study demonstrate the potential of T. ferdinandiana fruit and leaf extracts to inhibit Y. enterocolitica growth. The methanolic T. ferdinandiana leaf and fruit extracts, as well as the fruit ethyl acetate extract, were particularly potent growth inhibitors, with MIC values generally <350 µg/mL. However, before being acceptable for therapeutic uses, further cell line toxicity studies are required to verify the safety of these extracts. Furthermore, studies aimed at the purification and identification of the bioactive components are required to examine the mechanisms of action of these extracts.
